Enhancing pancreatic cancer treatment: the role of H101 oncolytic virus in irreversible electroporation
This combination boosts therapeutic effectiveness by activating the JNK-MAPK pathway and promoting tumor cell apoptosis. These findings suggest that the H101 oncolytic virus could serve as a valuable adjunct to improve the efficacy of IRE treatment.
Authors
- Pu Xi (ORCID: https://orcid.org/0009-0004-9412-9653)
- Lingmin Jiang (ORCID: https://orcid.org/0000-0002-8227-2880)
- Zehui Yao (ORCID: https://orcid.org/0000-0002-7590-1239)
- Dejun Zeng
- Dailei Qin (ORCID: https://orcid.org/0000-0001-7407-836X)
- Chaobin He (ORCID: https://orcid.org/0000-0002-8149-1264)
- Yu Zhang (ORCID: https://orcid.org/0000-0002-9505-1286)
- Miao Chen
Institutions
- Sun Yat-sen University (CN)
- Central Hospital of Wuhan (CN)
- Sun Yat-sen University Cancer Center (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.3389/fimmu.2025.1546242
- Citations
- 3
- Primary Topic
- Microbial Inactivation Methods
- Type
- article
- Field-Weighted Citation Impact
- 3.70